245 related articles for article (PubMed ID: 25967134)
21. Serological markers for monitoring historical changes in malaria transmission intensity in a highly endemic region of Western Kenya, 1994-2009.
Wong J; Hamel MJ; Drakeley CJ; Kariuki S; Shi YP; Lal AA; Nahlen BL; Bloland PB; Lindblade KA; Were V; Otieno K; Otieno P; Odero C; Slutsker L; Vulule JM; Gimnig JE
Malar J; 2014 Nov; 13():451. PubMed ID: 25416454
[TBL] [Abstract][Full Text] [Related]
22. CD36 c.1264 T>G null mutation impairs acquisition of IgG antibodies to Plasmodium falciparum MSP1₁₉ antigen and is associated with higher malaria incidences in Tanzanian children.
Kajeguka D; Mwanziva C; Daou M; Ndaro A; Matondo S; Mbugi E; Dolmans W; Chilongola J
Scand J Immunol; 2012 Mar; 75(3):355-60. PubMed ID: 22050542
[TBL] [Abstract][Full Text] [Related]
23. Protection of Malian children from clinical malaria is associated with recognition of multiple antigens.
Daou M; Kouriba B; Ouédraogo N; Diarra I; Arama C; Keita Y; Sissoko S; Ouologuem B; Arama S; Bousema T; Doumbo OK; Sauerwein RW; Scholzen A
Malar J; 2015 Feb; 14():56. PubMed ID: 25653026
[TBL] [Abstract][Full Text] [Related]
24. Cytophilic antibodies to Plasmodium falciparum glutamate rich protein are associated with malaria protection in an area of holoendemic transmission.
Lusingu JP; Vestergaard LS; Alifrangis M; Mmbando BP; Theisen M; Kitua AY; Lemnge MM; Theander TG
Malar J; 2005 Sep; 4():48. PubMed ID: 16194274
[TBL] [Abstract][Full Text] [Related]
25. Influence of infection on malaria-specific antibody dynamics in a cohort exposed to intense malaria transmission in northern Uganda.
Proietti C; Verra F; Bretscher MT; Stone W; Kanoi BN; Balikagala B; Egwang TG; Corran P; Ronca R; Arcà B; Riley EM; Crisanti A; Drakeley C; Bousema T
Parasite Immunol; 2013; 35(5-6):164-73. PubMed ID: 23473542
[TBL] [Abstract][Full Text] [Related]
26. Anti-sporozoite antibodies as alternative markers for malaria transmission intensity estimation.
Kusi KA; Bosomprah S; Dodoo D; Kyei-Baafour E; Dickson EK; Mensah D; Angov E; Dutta S; Sedegah M; Koram KA
Malar J; 2014 Mar; 13():103. PubMed ID: 24635830
[TBL] [Abstract][Full Text] [Related]
27. The effects of varying exposure to malaria transmission on development of antimalarial antibody responses in preschool children. XVI. Asembo Bay Cohort Project.
Singer LM; Mirel LB; ter Kuile FO; Branch OH; Vulule JM; Kolczak MS; Hawley WA; Kariuki SK; Kaslow DC; Lanar DE; Lal AA
J Infect Dis; 2003 Jun; 187(11):1756-64. PubMed ID: 12751033
[TBL] [Abstract][Full Text] [Related]
28. IgG antibodies to synthetic GPI are biomarkers of immune-status to both Plasmodium falciparum and Plasmodium vivax malaria in young children.
França CT; Li Wai Suen CSN; Carmagnac A; Lin E; Kiniboro B; Siba P; Schofield L; Mueller I
Malar J; 2017 Sep; 16(1):386. PubMed ID: 28946883
[TBL] [Abstract][Full Text] [Related]
29. Is Fc gamma receptor IIA (FcγRIIA) polymorphism associated with clinical malaria and Plasmodium falciparum specific antibody levels in children from Burkina Faso?
Cherif MK; Sanou GS; Bougouma EC; Diarra A; Ouédraogo A; Dolo A; Troye-Blomberg M; Cavanagh DR; Theisen M; Modiano D; Sirima SB; Nebié I
Acta Trop; 2015 Feb; 142():41-6. PubMed ID: 25447268
[TBL] [Abstract][Full Text] [Related]
30. Anti-malarial seroprevalence assessment during an elimination programme in Chabahar District, south-eastern Iran.
Zakeri S; van den Hoogen LL; Mehrizi AA; Karimi F; Raeisi A; Drakeley C
Malar J; 2016 Jul; 15(1):382. PubMed ID: 27448606
[TBL] [Abstract][Full Text] [Related]
31. Age interactions in the development of naturally acquired immunity to Plasmodium falciparum and its clinical presentation.
Aponte JJ; Menendez C; Schellenberg D; Kahigwa E; Mshinda H; Vountasou P; Tanner M; Alonso PL
PLoS Med; 2007 Jul; 4(7):e242. PubMed ID: 17676985
[TBL] [Abstract][Full Text] [Related]
32. The multiplicity of Plasmodium falciparum infections is associated with acquired immunity to asexual blood stage antigens.
Mayengue PI; Luty AJ; Rogier C; Baragatti M; Kremsner PG; Ntoumi F
Microbes Infect; 2009 Jan; 11(1):108-14. PubMed ID: 19028595
[TBL] [Abstract][Full Text] [Related]
33. Plasmodium falciparum clinical malaria in Dielmo, a holoendemic area in Senegal: no influence of acquired immunity on initial symptomatology and severity of malaria attacks.
Rogier C; Ly AB; Tall A; Cissé B; Trape JF
Am J Trop Med Hyg; 1999 Mar; 60(3):410-20. PubMed ID: 10466970
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness of a serological tool to predict malaria transmission intensity in an elimination setting.
Dewasurendra RL; Dias JN; Sepulveda N; Gunawardena GS; Chandrasekharan N; Drakeley C; Karunaweera ND
BMC Infect Dis; 2017 Jan; 17(1):49. PubMed ID: 28068925
[TBL] [Abstract][Full Text] [Related]
35. Maternal-foetal transfer of Plasmodium falciparum and Plasmodium vivax antibodies in a low transmission setting.
Charnaud SC; McGready R; Herten-Crabb A; Powell R; Guy A; Langer C; Richards JS; Gilson PR; Chotivanich K; Tsuboi T; Narum DL; Pimanpanarak M; Simpson JA; Beeson JG; Nosten F; Fowkes FJ
Sci Rep; 2016 Feb; 6():20859. PubMed ID: 26861682
[TBL] [Abstract][Full Text] [Related]
36. Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure.
Drakeley CJ; Corran PH; Coleman PG; Tongren JE; McDonald SL; Carneiro I; Malima R; Lusingu J; Manjurano A; Nkya WM; Lemnge MM; Cox J; Reyburn H; Riley EM
Proc Natl Acad Sci U S A; 2005 Apr; 102(14):5108-13. PubMed ID: 15792998
[TBL] [Abstract][Full Text] [Related]
37. Plasmodium falciparum infections are associated with agglutinating antibodies to parasite-infected erythrocyte surface antigens among healthy Kenyan children.
Bull PC; Lowe BS; Kaleli N; Njuga F; Kortok M; Ross A; Ndungu F; Snow RW; Marsh K
J Infect Dis; 2002 Jun; 185(11):1688-91. PubMed ID: 12023781
[TBL] [Abstract][Full Text] [Related]
38. Do antibody responses to malaria vaccine candidates influenced by the level of malaria transmission protect from malaria?
Nebie I; Tiono AB; Diallo DA; Samandoulougou S; Diarra A; Konate AT; Cuzin-Ouattara N; Theisen M; Corradin G; Cousens S; Ouattara AS; Ilboudo-Sanogo E; Sirima BS
Trop Med Int Health; 2008 Feb; 13(2):229-37. PubMed ID: 18304269
[TBL] [Abstract][Full Text] [Related]
39. Antibodies to the Plasmodium falciparum Proteins MSPDBL1 and MSPDBL2 Opsonize Merozoites, Inhibit Parasite Growth, and Predict Protection From Clinical Malaria.
Chiu CY; Hodder AN; Lin CS; Hill DL; Li Wai Suen CS; Schofield L; Siba PM; Mueller I; Cowman AF; Hansen DS
J Infect Dis; 2015 Aug; 212(3):406-15. PubMed ID: 25646353
[TBL] [Abstract][Full Text] [Related]
40. Measurement of Plasmodium falciparum transmission intensity using serological cohort data from Indonesian schoolchildren.
Bretscher MT; Supargiyono S; Wijayanti MA; Nugraheni D; Widyastuti AN; Lobo NF; Hawley WA; Cook J; Drakeley CJ
Malar J; 2013 Jan; 12():21. PubMed ID: 23327665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
